Hartland & Co »

Lyell Immunopharma shares owned by Hartland & Co

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $801k 40k 20.06

More positions owned by Hartland & Co

Vanguard Index Fds Put (VOO)
Paccar (PCAR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Intl (IDEV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Dimensional Etf Trust Intl High Profit (DIHP)
Vanguard Index Fds Total Stk Mkt (VTI)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Spdr Index Shs Fds State Street Spd (SPDW)

View all positions for Hartland & Co

Top funds holding Lyell Immunopharma

Arch Venture Corp
Vanguard Group
Foresite Capital Management IV
Orland Properties
Vanguard Capital Management
Almitas Capital
Foresite Capital Management V
Millennium Management
Citadel Advisors
venBio Partners
Alphabet
BlackRock
Geode Capital Management
Susquehanna International
Sc China Holding

View all funds holding Lyell Immunopharma